Oxford Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $22K | Sell |
1,381
-55,966
| -98% | -$892K | ﹤0.01% | 180 |
|
|
2019
Q4 | $1.23M | Buy |
57,347
+2,258
| +4% | +$48.3K | 0.03% | 737 |
|
|
2019
Q3 | $1.03M | Buy |
55,089
+35,336
| +179% | +$661K | 0.02% | 928 |
|
|
2019
Q2 | $516K | Buy |
+19,753
| New | +$516K | 0.01% | 1266 |
|
|
2017
Q1 | – | Sell |
-1,379
| Closed | -$33K | – | 1462 |
|
|
2016
Q4 | $33K | Sell |
1,379
-13,952
| -91% | -$334K | ﹤0.01% | 748 |
|
|
2016
Q3 | $563K | Buy |
+15,331
| New | +$563K | 0.02% | 606 |
|
|
2015
Q4 | – | Sell |
-10,480
| Closed | -$259K | – | 931 |
|
|
2015
Q3 | $259K | Sell |
10,480
-20,898
| -67% | -$516K | 0.01% | 561 |
|
|
2015
Q2 | $1.01M | Sell |
31,378
-33,926
| -52% | -$1.09M | 0.03% | 445 |
|
|
2015
Q1 | $2.33M | Buy |
65,304
+46,737
| +252% | +$1.67M | 0.06% | 332 |
|
|
2014
Q4 | $426K | Buy |
+18,567
| New | +$426K | 0.01% | 576 |
|
|
2014
Q2 | – | Sell |
-5,616
| Closed | -$218K | – | 760 |
|
|
2014
Q1 | $218K | Buy |
+5,616
| New | +$218K | 0.01% | 587 |
|